MEI Pharma, Inc. (MEIP)
NASDAQ: MEIP · Real-Time Price · USD
2.500
+0.040 (1.63%)
Dec 20, 2024, 4:00 PM EST - Market closed
MEI Pharma Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Revenue | - | 65.3 | 48.82 | 40.7 | 34.8 | 27.76 | Upgrade
|
| Revenue Growth (YoY) | - | 33.76% | 19.95% | 16.96% | 25.36% | 464.72% | Upgrade
|
| Cost of Revenue | 14.38 | 15.97 | 48.93 | - | 1.41 | 2.67 | Upgrade
|
| Gross Profit | -14.38 | 49.33 | -0.11 | 40.7 | 33.39 | 25.09 | Upgrade
|
| Selling, General & Admin | 19.84 | 22.98 | 32.33 | 30.54 | 24.41 | 16.72 | Upgrade
|
| Research & Development | 0.35 | 0.35 | 0.72 | 85.64 | 69.4 | 34.07 | Upgrade
|
| Operating Expenses | 20.19 | 23.33 | 33.05 | 116.18 | 93.81 | 50.78 | Upgrade
|
| Operating Income | -34.56 | 26 | -33.16 | -75.48 | -60.42 | -25.7 | Upgrade
|
| Interest & Investment Income | 2.54 | 3.28 | 3.35 | 0.28 | 0.51 | 1.4 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.05 | -0.04 | 1.58 | 20.75 | 18.61 | -22.87 | Upgrade
|
| EBT Excluding Unusual Items | -32.08 | 29.23 | -28.24 | -54.45 | -41.31 | -47.17 | Upgrade
|
| Merger & Restructuring Charges | -3.63 | -0.56 | -3.6 | - | - | - | Upgrade
|
| Asset Writedown | -10.9 | -10.9 | - | - | - | - | Upgrade
|
| Pretax Income | -46.6 | 17.78 | -31.84 | -54.45 | -41.31 | -47.17 | Upgrade
|
| Income Tax Expense | - | - | - | - | 0.01 | 0 | Upgrade
|
| Net Income | -46.6 | 17.78 | -31.84 | -54.45 | -41.31 | -47.17 | Upgrade
|
| Net Income to Common | -46.6 | 17.78 | -31.84 | -54.45 | -41.31 | -47.17 | Upgrade
|
| Shares Outstanding (Basic) | 7 | 7 | 7 | 6 | 6 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 7 | 7 | 7 | 6 | 6 | 5 | Upgrade
|
| Shares Change (YoY) | - | - | 6.49% | 9.31% | 25.69% | 25.83% | Upgrade
|
| EPS (Basic) | -6.99 | 2.67 | -4.78 | -8.75 | -7.34 | -10.36 | Upgrade
|
| EPS (Diluted) | -6.99 | 2.67 | -4.78 | -9.99 | -12.00 | -10.36 | Upgrade
|
| Free Cash Flow | -43.44 | -50.48 | -52.52 | -49.23 | -32.67 | 33.36 | Upgrade
|
| Free Cash Flow Per Share | -6.52 | -7.58 | -7.88 | -7.87 | -5.71 | 7.33 | Upgrade
|
| Gross Margin | - | 75.54% | -0.23% | 100.00% | 95.95% | 90.38% | Upgrade
|
| Operating Margin | - | 39.81% | -67.94% | -185.48% | -173.65% | -92.58% | Upgrade
|
| Profit Margin | - | 27.23% | -65.22% | -133.80% | -118.73% | -169.96% | Upgrade
|
| Free Cash Flow Margin | - | -77.31% | -107.59% | -120.95% | -93.90% | 120.20% | Upgrade
|
| EBITDA | -33.9 | 26.38 | -32.78 | -75.16 | -60.14 | -25.59 | Upgrade
|
| EBITDA Margin | - | 40.40% | -67.15% | -184.68% | -172.83% | -92.19% | Upgrade
|
| D&A For EBITDA | 0.66 | 0.38 | 0.39 | 0.33 | 0.29 | 0.11 | Upgrade
|
| EBIT | -34.56 | 26 | -33.16 | -75.48 | -60.42 | -25.7 | Upgrade
|
| EBIT Margin | - | 39.81% | -67.94% | -185.48% | -173.65% | -92.58% | Upgrade
|
| Revenue as Reported | - | 65.3 | 48.82 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.